Quetiapine Fumarate Tablet, Film Coated
Product Images NDC 63187-452

4 FDA label images from Proficient Rx Lp · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Quetiapine Fumarate (NDC 63187-452). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Quetiapine 25mg (Quetiapine 25mg 30)

Quetiapine 25mg (Quetiapine 25mg 30)
Label for Quetiapine Fumarate 25 mg film-coated tablets, containing 30 tablets per bottle. The label shows the product name, strength, dosage form, quantity, and manufacturer Intas Pharmaceuticals Limited, India. It is labeled for prescription use only and includes storage instructions and identification details. The labeler is Proficient Rx LP.*
FDA Label Image

Figure 1 Kaplan-meier Curves Of Time To Recurrence Of A Mood Event (study 7) (Quetiapine Fig1)

Figure 1 Kaplan-meier Curves Of Time To Recurrence Of A Mood Event (study 7) (Quetiapine Fig1)
A line graph depicting the proportion of patients with relapse (%) over time in weeks (0-100 weeks). Two groups are shown: QTP + Li/Val with a dashed line, showing a slower increase in relapse proportion, and PLA + Li/Val with a solid line, showing a higher and more rapid increase in relapse proportion.*
FDA Label Image

Figure 2 Kaplan-meier Curves Of Time To Recurrence Of A Mood Event (study 8) (Quetiapine Fig2)

Figure 2 Kaplan-meier Curves Of Time To Recurrence Of A Mood Event (study 8) (Quetiapine Fig2)
A line graph showing the proportion of patients with relapse (%) over time in weeks (0 to 100). Two groups are compared: QTP+LIVAL (dashed line) and PLA+LIVAL (solid line). The graph illustrates relapse rates increasing over time, with the PLA+LIVAL group showing a higher proportion of patients with relapse compared to the QTP+LIVAL group throughout the 100-week period.*
FDA Label Image

Chemstructure (Quetiapine Str)

Chemstructure (Quetiapine Str)
Chemical structure of quetiapine fumarate, showing the molecular arrangement of quetiapine and fumarate ions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.